Neurological symptoms of arterial occlusion within a year before surgery (symptomatic/asymptomatic)
15/5
N.A.
N.A.
Myocardial infarction in the past or ischemic coronary disease (yes/no)
7/13
0/40
Medications (grouped) % of the group:
Calcium channel blockers
40
5
Beta-blockers
30
2.5
ACE inhibitors
50
5
Diuretics
30
2.5
Statins
80
2.5
Acetylsalicylic acid or other antiplatelet drugs
85
2.5
Heparin (LMWH)
15
0
Insulin
15
0
Oral hypoglycemic medications
60
0
Laboratory test results
White blood count (G/l)
8.5 (7.85–10.45)
5.35 (4.85–6.05)
Platelet count (G/l)
222 (188–332)
219 (185–244)
Total cholesterol (mmol/l)
3.55 (2.78–4.48)
4.51 (3.77–5.23)
HDL-C (mmol/l)
1.26 (0.98–1.55)
1.58 (1.35–1.81)
HDL-C (mmol/l) F
1.37 (1.06–1.68)
1.73 (1.60–2.12)
HDL-C (mmol/l) M
1.22 (1.04–1.41)
1.49 (1.24–1.73)
LDL-C (mmol/l)
1.90 (1.26–2.51)
2.49 (1.81–3.16)
Triglycerides (mmol/l)
1.06 (0.62–1.50)
0.81 (0.60–1.10)
Creatinine (µmol/l)
72.3 (60.9–85.6)
78.5 (66.2–90.8)
Creatinine (µmol/l) F
56.4 (54.2–61.9)
71.4 (62.6–80.3)
Creatinine (µmol/l) M
79.4 (69.7–90.8)
86.4 (75.0–97.9)
Data are presented as mean ± SD for parameter showing normal distribution or as median ± interquartile range when the distribution shows discrepancies from normal. was considered statistically significant. BMI: body mass index; ICA: internal carotid artery; N.A.: not applicable; TIA: transient ischemic attack; ACE: angiotensin-converting enzyme; LMWH: low-molecular-weight heparin; HDL-C: high-density lipoprotein cholesterol; F: female; M: male; LDL-C: low-density lipoprotein cholesterol; and SD: standard deviation.
